石四药集团(02005.HK)：酒石酸托特罗定缓释胶囊(4mg)获药品生产注册批件

Core Viewpoint - The company has received the production registration approval for Trospium Chloride Extended-Release Capsules (4mg) from the National Medical Products Administration of China, marking it as the third domestic company to obtain this approval [1] Group 1: Company Developments - The approval is classified as a Class 4 chemical drug and is considered equivalent to passing the consistency evaluation [1] - Trospium Chloride Extended-Release Capsules are primarily used for the treatment of overactive bladder syndrome [1]